Credit Concentrations	9 Months Ended
Sep. 30, 2024
Risks and Uncertainties [Abstract]
Credit Concentrations	(3) Credit Concentrations Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable. The Company maintains its cash and cash equivalents and marketable securities, which at times may exceed federally insured limits, in deposit accounts at major financial institutions. For the three and nine months ended September 30, 2024 and 2023, no single buyer accounted for more than 10% of the Company's revenue. As of September 30, 2024, and December 31, 2023, no single buyer accounted for more than 10% of the Company’s accounts receivable. A majority of the Company’s buyers are located in the United States.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/275/tableOfContent

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration